# To Evaluate Ezetimibe/Simvastatin and Niacin (Extended Release Tablet) in Patients With Type IIa or Type IIb Hyperlipidemia (0653A-091)(COMPLETED)

> **NCT00271817** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 1220 (actual)

## Conditions studied

- Hypercholesterolemia

## Interventions

- **DRUG:** Comparator: ezetimibe/simvastatin + niacin (ER)
- **DRUG:** Comparator: Placebo to ezetimibe/simvastatin
- **DRUG:** Comparator: niacin (ER) tablet
- **DRUG:** Comparator: ezetimibe (+) simvastatin
- **DRUG:** Comparator: Placebo to Niacin (ER)
- **DRUG:** Comparator: ezetimibe/simvastatin and niacin (ER)
- **DRUG:** Comparator: ezetimibe and simvastatin
- **DRUG:** Comparator: Placebo to niacin (ER)

## Key facts

- **NCT ID:** NCT00271817
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-12
- **Primary completion:** 2008-02
- **Final completion:** 2008-02
- **Target enrollment:** 1220 (ACTUAL)
- **Last updated:** 2024-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00271817

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00271817, "To Evaluate Ezetimibe/Simvastatin and Niacin (Extended Release Tablet) in Patients With Type IIa or Type IIb Hyperlipidemia (0653A-091)(COMPLETED)". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00271817. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*